| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |